MapLight Therapeutics

Recent news

• Morgan Stanley Maintains MapLight Therapeutics(MPLT.US) With Hold Rating, Maintains Target Price $21
  Market Newswire · 2026/8/17
• Rating change
  A Quick Look at Today's Ratings for MapLight Therapeutics(MPLT.US), With a Forecast Between $21 to $45
  Market Newswire · 2026/7/28
• Rating change
  BMO Capital Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Maintains Target Price $46
  Market Newswire · 2026/7/21
• Rating change
  UBS Downgrades MapLight Therapeutics(MPLT.US) to Hold Rating, Cuts Target Price to $13
  Market Newswire · 2026/8/10
• Rating change
  Morgan Stanley Downgrades MapLight Therapeutics(MPLT.US) to Hold Rating, Cuts Target Price to $21
  Market Newswire · 2026/7/29
• Needham Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Cuts Target Price to $43
  Market Newswire · 2026/8/31
• Guggenheim Initiates MapLight Therapeutics(MPLT.US) With Hold Rating
  Market Newswire · 2026/10/6
• Rating change
  Craig-Hallum Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Cuts Target Price to $25
  Market Newswire · 2026/7/28
• Rating change
  Analysts Are Bullish on Top NA Stocks: Safe Pro Group, Inc. (SPAI), MapLight Therapeutics, Inc. (MPLT)
  TipRanks · 2026/7/28
• Rating change
  MapLight Therapeutics, Inc. (MPLT) Gets a Buy From Jefferies
  TipRanks · 2026/7/30
• Rating change
  LifeSci Capital Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Maintains Target Price $37
  Market Newswire · 2026/8/14
• Rating change
  Analysts Are Bullish on Top NA Stocks: Syensqo SA/NV (SHBBF), MapLight Therapeutics, Inc. (MPLT)
  TipRanks · 2026/7/28
• Rating change
  Analysts Offer Insights on NA Companies: CAMP4 Therapeutics Corporation (CAMP), MapLight Therapeutics, Inc. (MPLT) and Andersen Group, Inc. Class A (ANDG)
  TipRanks · 2026/8/14
• Rating change
  CCORF Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Raises Target Price to $43
  Market Newswire · 2026/7/24
• Rating change
  Analysts' Top NA Picks: Solv Energy (MWH), MapLight Therapeutics, Inc. (MPLT)
  TipRanks · 2026/8/14
• Rating change
  Morgan Stanley Keeps Their Hold Rating on MapLight Therapeutics, Inc. (MPLT)
  TipRanks · 2026/8/17
• UBS Maintains MapLight Therapeutics(MPLT.US) With Hold Rating, Maintains Target Price $13
  Market Newswire · 2026/8/11
• Rating change
  BMO Capital Initiates MapLight Therapeutics(MPLT.US) With Buy Rating, Announces Target Price $20
  Market Newswire · 2026/8/14
• UBS Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Raises Target Price to $52
  Market Newswire · 2026/7/22
• Rating change
  Analysts' Top NA Picks: BKV Corporation (BKV), MapLight Therapeutics, Inc. (MPLT)
  TipRanks · 2026/7/22

Headlines are aggregated automatically and are not independently verified or edited by our team.